SEED BIOTECH Trademark

Trademark Overview


On Monday, October 13, 2025, a trademark application was filed for SEED BIOTECH with the United States Patent and Trademark Office. The USPTO has given the SEED BIOTECH trademark a serial number of 99439931. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, March 16, 2026. This trademark is owned by Seed Biotech, Inc.. The SEED BIOTECH trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue
seed biotech

General Information


Serial Number99439931
Word MarkSEED BIOTECH
Filing DateMonday, October 13, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, March 16, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 7, 2026

Trademark Statements


Goods and ServicesHuman allograft tissue
NOT AVAILABLE"BIOTECH"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 13, 2025
Primary Code005
First Use Anywhere DateSaturday, January 1, 2011
First Use In Commerce DateSunday, January 1, 2012

Trademark Owner History


Party NameSeed Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Addresschattanooga, TN 37405
US

Trademark Events


Event DateEvent Description
Monday, October 13, 2025NEW APPLICATION ENTERED
Monday, October 13, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 13, 2025APPLICATION FILING RECEIPT MAILED
Monday, March 2, 2026ASSIGNED TO EXAMINER
Wednesday, March 4, 2026NON-FINAL ACTION WRITTEN
Wednesday, March 4, 2026NON-FINAL ACTION E-MAILED
Wednesday, March 4, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 4, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 4, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 4, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 10, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords


biotech seed tissue allograft human